SeaSpine Holdings Corporation Begins Trading on NASDAQ (press release)
New public spine company formed from the former SeaSpine and Theken acquisitions
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the completion of its tax-free spinoff from Integra LifeSciences Holdings Corporation (NASDAQ: IART). Beginning today, SeaSpine shares will commence “regular-way” trading on the NASDAQ Global Market.
“Today marks a meaningful milestone for SeaSpine, as we reposition the Company for innovation and growth,” said Keith Valentine, President and Chief Executive Officer of SeaSpine. “We are well positioned in the spine market with a leading orthobiologics platform, a robust R&D pipeline with several novel product launches expected this calendar year, and a strong balance sheet with $47 million of cash and no debt post-spin to fund growth initiatives. We are confident in our ability to deliver long-term growth and value creation to our shareholders as an independent company.”
The distribution of SeaSpine common stock took place on July 1, 2015. Each holder of Integra comm...
